Home/Filings/4/0001810701-25-000007
4//SEC Filing

Palasis Maria 4

Accession 0001810701-25-000007

CIK 0001674632other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 4:20 PM ET

Size

7.0 KB

Accession

0001810701-25-000007

Insider Transaction Report

Form 4
Period: 2025-12-01
Transactions
  • Sale

    Common Stock

    2025-12-01$29.33/sh906$26,5708,935 total
  • Sale

    Common Stock

    2025-12-01$29.96/sh500$14,9828,435 total
Footnotes (3)
  • [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.
  • [F2]The weighted average sale price for the transaction reported was $29.3269 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • [F3]The weighted average sale price for the transaction reported was $29.9640 and the range of prices were between $29.80 and $30.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Issuer

Beta Bionics, Inc.

CIK 0001674632

Entity typeother

Related Parties

1
  • filerCIK 0001810701

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:20 PM ET
Size
7.0 KB